Training in Adults With Parkinson's Disease
PARKINSON DISEASE (Disorder)
What this study involves
The registry does not currently label this study as recruiting. Ask about its status before planning a screening visit.
- Study type
- Interventional
- Phase
- Not applicable
- Age range
- 60 years - Not specified
- Sex eligible
- All sexes
- Healthy volunteers
- Not accepted
- Participants
- 20 Estimated
These are starting points, not an eligibility decision. The research team must review the full requirements.
About the research
Patients with Parkinson's disease experience progressive deconditioning of the respiratory muscles, leading to weakness and potential ventilatory impairments. Evidence indicates that physical exercise positively affects these muscles in people with various clinical conditions. This study will evaluate the effects of multicomponent and resistance training on respiratory parameters and physical and functional capacities in individuals with Parkinson's disease. A total of 40 patients will be randomly allocated to two groups: 20 individuals in the multicomponent training group and 20 in the resistance training group. Both groups will undergo a three-month intervention with two sessions per week. All participants must continue standard pharmacological treatment for Parkinson's disease. Respiratory parameters will be assessed using respiratory pressure measurement and spirometry. Physical and functional capacities will be assessed using the Rikli and Jones test battery.
Who may be able to participate?
The list below is the sponsor’s full registry wording. It can include conditions, prior treatment, test results and other requirements. A match in search does not mean you qualify.
Inclusion Criteria:
- Hoehn and Yahr stages 1-3
- Physical and mental requirements,
- No history of exercise training in the preceding three months.
- Standard pharmacological treatment for PD throughout the 12-week study period.
Exclusion Criteria:
- Mini-Mental State Examination score \<24
- Unstable cardiovascular disease or any other uncontrolled chronic condition
Treatment, groups and participation
The registry may describe treatments and study duration without a complete visit calendar. Ask the study team for the exact schedule, procedures, risks, costs and alternatives. Keep your usual care plan unless your treating clinician tells you otherwise.
- Assignment
- Random assignment
- Masking
- Single masked
Aerobic training
The first group will undergo multicomponent training for three months, with two sessions per week
Other: Exercise
Resistance training
The second group will undergo resistance training for the same period
Other: Exercise
Exercise OTHER
Resistence training
What researchers are measuring
Outcome measures describe what is being studied. They are not proof that a treatment works.
Primary measures
Inspiratory pressure
Time frame: three weeks
Respiratory muscle strength will be assessed using a manovacuometer with a range of -300 to +300 cmH2O. Respiratory muscle strength during inspiration will be assessed.
Forced Vital Capacity
Time frame: three weeks
Forced vital capacity, expressed in liters, will be assessed based on the maximum volume of inspired air, which will be measured in liters using a spirometer
Review the complete result tables and limitations in the official record.
Open official results ↗Research locations (0)
The overall study status and a local site’s status can differ. Confirm that location’s availability before traveling.
No locations are listed. Use the official study contact.
Study team and timeline
- Lead sponsor
- Universidade do Estado do Pará
- Study start
- Nov 15, 2026 Estimated
- Primary completion
- Dec 20, 2027 Estimated
- Study completion
- Jan 15, 2028 Estimated
- First posted
- Nov 10, 2026 Actual
- Last updated
- Nov 10, 2026 Actual
Official study contacts
Official study title
Training on Respiratory Parameters in Older Adults With Parkinson's Disease
Ask Wellness Clinical Research
Your message goes to WCR, including when this study is run by another organization. WCR may offer general guidance but may not operate this trial, have access to its team or be able to enroll you.
Source: ClinicalTrials.gov API v2. Information is submitted by sponsors and investigators. NLM does not approve the safety or science of all listed studies. Registry disclaimer.
Retrieved: Nov 12, 2026 · Last registry update: Nov 10, 2026
